BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20377880)

  • 1. Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.
    Yang GF; He WP; Cai MY; He LR; Luo JH; Deng HX; Guan XY; Zeng MS; Zeng YX; Xie D
    BMC Cancer; 2010 Apr; 10():133. PubMed ID: 20377880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
    Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
    Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma.
    Yang GP; He WP; Tan JF; Yang ZX; Fan RR; Ma NF; Wang FW; Chen L; Li Y; Shen HW; You ZS; Xie D; Yang GF
    Int J Gynecol Cancer; 2019 Oct; 29(8):1280-1284. PubMed ID: 31570543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells.
    Song LB; Zeng MS; Liao WT; Zhang L; Mo HY; Liu WL; Shao JY; Wu QL; Li MZ; Xia YF; Fu LW; Huang WL; Dimri GP; Band V; Zeng YX
    Cancer Res; 2006 Jun; 66(12):6225-32. PubMed ID: 16778197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours.
    Häyry V; Tynninen O; Haapasalo HK; Wölfer J; Paulus W; Hasselblatt M; Sariola H; Paetau A; Sarna S; Niemelä M; Wartiovaara K; Nupponen NN
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):555-63. PubMed ID: 18346113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins.
    Kim JH; Yoon SY; Kim CN; Joo JH; Moon SK; Choe IS; Choe YK; Kim JW
    Cancer Lett; 2004 Jan; 203(2):217-24. PubMed ID: 14732230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bmi-1 is a prognostic marker in bladder cancer.
    Qin ZK; Yang JA; Ye YL; Zhang X; Xu LH; Zhou FJ; Han H; Liu ZW; Song LB; Zeng MS
    BMC Cancer; 2009 Feb; 9():61. PubMed ID: 19228380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
    Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.
    Vonlanthen S; Heighway J; Altermatt HJ; Gugger M; Kappeler A; Borner MM; van Lohuizen M; Betticher DC
    Br J Cancer; 2001 May; 84(10):1372-6. PubMed ID: 11355949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer.
    Honig A; Weidler C; Häusler S; Krockenberger M; Buchholz S; Köster F; Segerer SE; Dietl J; Engel JB
    Anticancer Res; 2010 May; 30(5):1559-64. PubMed ID: 20592341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer.
    Li DW; Tang HM; Fan JW; Yan DW; Zhou CZ; Li SX; Wang XL; Peng ZH
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):997-1006. PubMed ID: 20024662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.
    Rao ZY; Cai MY; Yang GF; He LR; Mai SJ; Hua WF; Liao YJ; Deng HX; Chen YC; Guan XY; Zeng YX; Kung HF; Xie D
    Carcinogenesis; 2010 Sep; 31(9):1576-83. PubMed ID: 20668008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer.
    Bhattacharya R; Nicoloso M; Arvizo R; Wang E; Cortez A; Rossi S; Calin GA; Mukherjee P
    Cancer Res; 2009 Dec; 69(23):9090-5. PubMed ID: 19903841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity.
    Xin T; Zhang FB; Sui GJ; Jin XM
    Br J Biomed Sci; 2012; 69(2):62-6. PubMed ID: 22872929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.
    Breuer RH; Snijders PJ; Sutedja GT; Sewalt RG; Otte AP; Postmus PE; Meijer CJ; Raaphorst FM; Smit EF
    Lung Cancer; 2005 Jun; 48(3):299-306. PubMed ID: 15892997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.
    He WP; Li Q; Zhou J; H ZS; Kung HF; Guan XY; Xie D; Yang GF
    Neoplasma; 2015; 62(6):932-7. PubMed ID: 26458314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.